|
Uteruskrebs ? 39 Arzneien anthraq. ars-ac. ars-br. ars-h. ars-met. ars-n. ars-pyr. ars-s-f. ars-s-r. asperg-n. carc-ut-ad. carc-ut-p. chr-met. cina. cisplat. equis-a. ethin-cypr. euph. foll. hell-v. hydrin-m. ign. kali-chl. lac-c. lappa. led. lem-m. mag-chl. meli. mom-b. naphthoq. op. plat-i. quinhydr. sabal. sanic. sed-r. tamox. ur-ac. keine Fälle=ein- >1-2 Fälle=zwei- >2 Fälle=Drei- >5 Fälle=Vier- >10 Fälle=FÜNF-wertig ()=BegleitTherapie *=palliativ **=TeilWirkung ***=1-Jahr ****5-Jahre-Nachbeobachtung |
| ^ | anthraq | lby |
| ^ | ars-ac | lby |
| ^ | ars-br | lby |
| ^ | ars-h | lby |
| ^ | ars-met | lby |
| ^ | ars-n | lby |
| ^ | ars-pyr | lby |
| ^ | ars-s-f | lby |
| ^ | ars-s-r | lby |
| ^ | asperg-n | lby |
| ^ | carc-ut-ad | lby |
| ^ | carc-ut-p | lby |
| ^ | chr-met | lby |
| ^ | cina | lby |
| ^ | cisplat | klc |
| ^ | equis-a | lby |
| ^ | ethin-cypr | lby |
| ^ | euph | lby |
| ^ | foll | lby |
| ^ | hell-v | lby |
| ^ | hydrin-m | klc |
| ^ | ign | lby |
| ^ | kali-chl | lby |
| ^ | lac-c | lby |
| ^ | lappa | lby |
| ^ | led | lby |
| ^ | lem-m | lby |
| ^ | mag-chl | lby |
| ^ | meli | lby |
| ^ | mom-b | lby |
| ^ | naphthoq | lby |
| ^ | op | lby |
| ^ | plat-i | klc |
| ^ | quinhydr | lby |
| ^ | sabal | lby |
| ^ | sanic | lby |
| ^ | sed-r | bn |
| ^ | tamox | lby |
| ^ | ur-ac | lby |